NPM1可测量的残留疾病:叙述性审查
Yadav Chitresh1, Nathany Shrinidhi1, Kumar Nikhil M1
1Hematology and BMT, Fortis Memorial Research Institute, Gurugram, India.
概括
在急性髓性白血病 (AML) 中检测可测量的残留疾病 (MRD) 具有突变的核素1 (NPM1) 是至关重要的. 建议采用使用各种测试方式的综合方法,以准确监测AML患者的NPM1MRD.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子诊断学 分子诊断学
背景情况:
- 突变的NPM1定义了一个独特的AML亚型和一个有利的风险组.
- 在NPM1-突变的AML中检测可测量的残留疾病 (MRD) 改善了患者的治疗结果.
- 目前的NPM1 MRD检测技术存在局限性,需要采用综合方法.
研究的目的:
- 审查和详细介绍在AML中NPM1MRD的各种测试方式.
- 强调对NPM1 MRD检测采用综合方法的重要性.
- 提高对标准化NPM1MRD监测的需要的认识.
主要方法:
- 文学叙事审查. 文学叙事审查.
- 在PubMed,Embase和Scopus中使用关键词"NPM1"",MRD"",NGS"进行文献搜索.
- 包含40篇文章,没有正式的包含/排除标准或统计分析.
主要成果:
- 对于NPM1MRD检测,存在多种技术,每个技术都有独特的优点和缺点.
- 建议采用综合方法,以减轻NPM1MRD评估中的潜在虚假阴性.
- 基因组MRD监测,特别是NPM1,有助于指导AML治疗,包括移植时间.
结论:
- 精确的NPM1MRD监测对于优化AML治疗策略至关重要.
- 建议采用对NPM1MRD测试的综合和综合方法.
- 未来的方向可能涉及人工智能和机器学习,以改善NPM1-突变AML的风险分层.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...